Stay updated on Pembrolizumab and Itacitinib for NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Itacitinib for NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Itacitinib for NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision: v3.7.0 appears on the page, replacing Revision: v3.6.6. This reflects an internal update to the page's revision/versioning, not a change to the study content presented to users.
    Difference
    0.1%
    Check dated 2026-09-17T22:04:51.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    A new revision entry Revision: v3.6.6 has been added and the prior Revision: v3.6.5 has been removed. This reflects a minor system or documentation update for the page rather than changes to the study details.
    Difference
    0.1%
    Check dated 2026-08-27T19:44:36.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Removed the Notice header and the text about intermittent NCBI service delays from the page, eliminating the site-wide outage message and leaving the study information intact.
    Difference
    0.1%
    Check dated 2026-08-20T20:06:09.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    A site-wide notice about intermittent delays was added. The revision version was updated from v3.6.4 to v3.6.5.
    Difference
    0.2%
    Check dated 2026-08-13T18:38:37.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.3 to v3.6.4. This indicates a minor metadata update to the record rather than a substantive change to the study details.
    Difference
    0.1%
    Check dated 2026-07-23T08:54:57.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    No additions or deletions were reported; there are no textual updates to summarize.
    Difference
    0.1%
    Check dated 2026-07-16T08:28:26.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Itacitinib for NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Itacitinib for NSCLC Clinical Trial page.